KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Oscar Health (OSCR) EPS (Weighted Average and Diluted) (2020 - 2025)

Oscar Health (OSCR) has disclosed EPS (Weighted Average and Diluted) for 6 consecutive years, with -$1.34 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Weighted Average and Diluted) fell 143.64% year-over-year to -$1.34, compared with a TTM value of -$1.69 through Dec 2025, down 3480.0%, and an annual FY2025 reading of -$1.69, down 1790.0% over the prior year.
  • EPS (Weighted Average and Diluted) was -$1.34 for Q4 2025 at Oscar Health, down from -$0.38 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.92 in Q1 2025 and bottomed at -$1.34 in Q4 2025.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.44, with a median of -$0.46 recorded in 2022.
  • The sharpest move saw EPS (Weighted Average and Diluted) soared 444.44% in 2024, then plummeted 545.0% in 2025.
  • Year by year, EPS (Weighted Average and Diluted) stood at -$0.83 in 2021, then dropped by 26.51% to -$1.05 in 2022, then surged by 36.19% to -$0.67 in 2023, then grew by 17.91% to -$0.55 in 2024, then tumbled by 143.64% to -$1.34 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for OSCR at -$1.34 in Q4 2025, -$0.38 in Q3 2025, and -$0.89 in Q2 2025.